Docetaxel and Erlotinib in Treating Older Patients With Prostate Cancer

NCT00087035 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

1

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: docetaxel
DRUG: erlotinib hydrochloride

Sponsor

Jonsson Comprehensive Cancer Center

Collaborators

[object Object]
[object Object]